Señales en vivo de LHDX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mar 2023 @ 16:00):

Stats
Volumen de hoy	36.26M
Volumen promedio	21.45M
Capitalización de mercado	18.36M
EPS	$0 ( 2023-05-10 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.144
ATR14	$0.0630 (13.93%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-03	Engelson Erik T.	Buy	574 666	Common Stock
2023-03-03	Engelson Erik T.	Sell	574 666	Common Stock
2023-03-03	Engelson Erik T.	Sell	60 000	Common Stock
2023-03-03	Engelson Erik T.	Sell	574 666	Common Stock
2023-03-03	Narido Richard Clavano	Sell	10 674	Common Stock

INSIDER POWER
-77.90
Last 96 transactions
Buy: 17 602 742 \| Sell: 22 464 128

Volumen Correlación

Largo: 0.09 (neutral)

Corto: 0.47 (neutral)

Signal:(52.543) Neutral

Lucira Health, Inc. Correlación

10 Correlaciones Más Positivas
XPDI	0.906
GOODM	0.898
PIII	0.889
EJH	0.885
SMIT	0.884
MGPI	0.882
VTNR	0.881
VRM	0.88
MLVF	0.879
BJDX	0.876

10 Correlaciones Más Negativas
CPLP	-0.903
IPVI	-0.899
SRPT	-0.891
FFNW	-0.89
IQ	-0.889
CYCCP	-0.888
DUET	-0.887
FRGI	-0.887
IDYA	-0.887
VSTM	-0.885

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lucira Health, Inc. Correlación - Moneda/Commodity

-0.62
( weak negative )

-0.74
( moderate negative )

0.00
( neutral )

-0.21
( neutral )

0.60
( weak )

Lucira Health, Inc. Finanzas

Annual	2021
Ingresos:	$93.06M
Beneficio Bruto:	$10.22M (10.99 %)
EPS:	$-1.807

FY	2021
Ingresos:	$93.06M
Beneficio Bruto:	$10.22M (10.99 %)
EPS:	$-1.807

FY	2020
Ingresos:	$269 000
Beneficio Bruto:	$-1.67M (-621.56 %)
EPS:	$-1.041

FY	2019
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.070

Financial Reports:

No articles found.

Lucira Health, Inc.

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.